156 related articles for article (PubMed ID: 37542341)
1. Transgenic disruption of endogenous glucocorticoid signaling in osteoblasts does not alter long-term K/BxN serum transfer-induced arthritis.
Maleitzke T; Wiebe E; Huscher D; Spies CM; Tu J; Gaber T; Zheng Y; Buttgereit F; Seibel MJ; Zhou H
Arthritis Res Ther; 2023 Aug; 25(1):140. PubMed ID: 37542341
[TBL] [Abstract][Full Text] [Related]
2. Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K/BxN mouse serum-induced arthritis in vivo.
Buttgereit F; Zhou H; Kalak R; Gaber T; Spies CM; Huscher D; Straub RH; Modzelewski J; Dunstan CR; Seibel MJ
Arthritis Rheum; 2009 Jul; 60(7):1998-2007. PubMed ID: 19565501
[TBL] [Abstract][Full Text] [Related]
3. Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling.
Spies CM; Wiebe E; Tu J; Li A; Gaber T; Huscher D; Seibel MJ; Zhou H; Buttgereit F
BMC Musculoskelet Disord; 2014 Feb; 15():31. PubMed ID: 24491163
[TBL] [Abstract][Full Text] [Related]
4. Transgenic Disruption of Glucocorticoid Signaling in Osteoblasts Attenuates Joint Inflammation in Collagen Antibody-Induced Arthritis.
Tu J; Zhang Y; Kim S; Wiebe E; Spies CM; Buttgereit F; Cooper MS; Seibel MJ; Zhou H
Am J Pathol; 2016 May; 186(5):1293-301. PubMed ID: 26988651
[TBL] [Abstract][Full Text] [Related]
5. Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage.
Tu J; Stoner S; Fromm PD; Wang T; Chen D; Tuckermann J; Cooper MS; Seibel MJ; Zhou H
FASEB J; 2018 Jan; 32(1):478-487. PubMed ID: 28928247
[TBL] [Abstract][Full Text] [Related]
6. Disruption of glucocorticoid signalling in osteoblasts attenuates age-related surgically induced osteoarthritis.
Tu J; Zhang P; Ji Z; Henneicke H; Li J; Kim S; Swarbrick MM; Wu Y; Little CB; Seibel MJ; Zhou H
Osteoarthritis Cartilage; 2019 Oct; 27(10):1518-1525. PubMed ID: 31176016
[TBL] [Abstract][Full Text] [Related]
7. Gasdermin D deficiency attenuates arthritis induced by traumatic injury but not autoantibody-assembled immune complexes.
Yang T; Sun K; Wang C; Swarnkar G; Quan S; Kress D; Xiao J; Alippe Y; Zheng H; Brophy RH; Hao D; McAlinden A; Abu-Amer Y; Shen J; Mbalaviele G
Arthritis Res Ther; 2021 Nov; 23(1):286. PubMed ID: 34784954
[TBL] [Abstract][Full Text] [Related]
8. Collagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis.
Singh A; Rajasekaran N; Hartenstein B; Szabowski S; Gajda M; Angel P; Bräuer R; Illges H
Arthritis Res Ther; 2013; 15(6):R222. PubMed ID: 24369907
[TBL] [Abstract][Full Text] [Related]
9. 11β-Hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice.
Coutinho AE; Gray M; Brownstein DG; Salter DM; Sawatzky DA; Clay S; Gilmour JS; Seckl JR; Savill JS; Chapman KE
Endocrinology; 2012 Jan; 153(1):234-40. PubMed ID: 22067318
[TBL] [Abstract][Full Text] [Related]
10. Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss.
Yang J; Li J; Cui X; Li W; Xue Y; Shang P; Zhang H
Bone; 2020 Jan; 130():115108. PubMed ID: 31704341
[TBL] [Abstract][Full Text] [Related]
11. Chronic Mild Stress Causes Bone Loss via an Osteoblast-Specific Glucocorticoid-Dependent Mechanism.
Henneicke H; Li J; Kim S; Gasparini SJ; Seibel MJ; Zhou H
Endocrinology; 2017 Jun; 158(6):1939-1950. PubMed ID: 28368468
[TBL] [Abstract][Full Text] [Related]
12. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
[TBL] [Abstract][Full Text] [Related]
13. Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency.
Martin P; Talabot-Ayer D; Seemayer CA; Vigne S; Lamacchia C; Rodriguez E; Finckh A; Smith DE; Gabay C; Palmer G
Arthritis Res Ther; 2013 Jan; 15(1):R13. PubMed ID: 23324173
[TBL] [Abstract][Full Text] [Related]
14. Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing.
Weber AJ; Li G; Kalak R; Street J; Buttgereit F; Dunstan CR; Seibel MJ; Zhou H
Steroids; 2010 Mar; 75(3):282-6. PubMed ID: 20096296
[TBL] [Abstract][Full Text] [Related]
15. Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis.
He X; Liu J; Liang C; Badshah SA; Zheng K; Dang L; Guo B; Li D; Lu C; Guo Q; Fan D; Bian Y; Feng H; Xiao L; Pan X; Xiao C; Zhang B; Zhang G; Lu A
EBioMedicine; 2019 Mar; 41():538-555. PubMed ID: 30824383
[TBL] [Abstract][Full Text] [Related]
16. ApoE deficiency exacerbates the development and sustainment of a semi-chronic K/BxN serum transfer-induced arthritis model.
Archer AM; Saber R; Rose S; Shaffer A; Misharin AV; Tsai F; Haines Iii GK; Dominguez S; Eren M; Vaughan DE; Cuda CM; Perlman H
J Transl Med; 2016 Jun; 14(1):170. PubMed ID: 27287704
[TBL] [Abstract][Full Text] [Related]
17. Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice.
Kalak R; Zhou H; Street J; Day RE; Modzelewski JR; Spies CM; Liu PY; Li G; Dunstan CR; Seibel MJ
Bone; 2009 Jul; 45(1):61-7. PubMed ID: 19358901
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis.
Fenton CG; Webster JM; Martin CS; Fareed S; Wehmeyer C; Mackie H; Jones R; Seabright AP; Lewis JW; Lai YC; Goodyear CS; Jones SW; Cooper MS; Lavery GG; Langen R; Raza K; Hardy RS
Arthritis Res Ther; 2019 Aug; 21(1):182. PubMed ID: 31370858
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-8 deficiency increases joint inflammation and bone erosion in the K/BxN serum-transfer arthritis model.
García S; Forteza J; López-Otin C; Gómez-Reino JJ; González A; Conde C
Arthritis Res Ther; 2010; 12(6):R224. PubMed ID: 21190566
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis.
Koenen M; Culemann S; Vettorazzi S; Caratti G; Frappart L; Baum W; Krönke G; Baschant U; Tuckermann JP
Ann Rheum Dis; 2018 Nov; 77(11):1610-1618. PubMed ID: 29997111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
